Stockholders' Deficit

12 Months Ended

Dec. 31, 2020

Stockholders' Deficit [Line Items]

Stockholders' Equity Note Disclosure [Text Block]

14.  Stockholders’ Deficit

During 2020 and 2019, the Board of Directors did not declare any quarterly cash dividends on the Company’s Common Stock.

The Company was authorized to issue 2,500,000 shares of preferred stock as of December 31, 2020, of which (i) 416,500 shares were designated as Series A Convertible Preferred Stock, none of which were outstanding, (ii) 51,000 shares were designated as SBCPS, none of which were outstanding, and (iii) 2,032,500 shares were not yet designated.  The undesignated preferred stock would contain such rights, preferences, privileges and restrictions as may be fixed by our Board of Directors.

Shares of the Company’s Common Stock reserved for future issuance in connection with convertible securities and stock option plans were 1.8 million and 260,000 at December 31, 2020 and 2019, respectively.

Accumulated other comprehensive loss is comprised of approximately $7.6 million and $6.8 million of unrecognized pension costs at December 31, 2020 and 2019, respectively, and $245,000 and $194,000 of unrealized foreign currency translation gains at December 31, 2020 and 2019, respectively.

The components of accumulated other comprehensive loss are as follows:

In thousands	Pension plan actuarial loss		Foreign currency translation gain (loss)		Total
Balances at January 1, 2019	$	(6,470)	$	76	$	(6,394)
Actuarial loss		(342)		-		(342)
Translation gain		-		118		118
Balances at December 31, 2019		(6,812)		194		(6,618)
Actuarial loss		(755)		-		(755)
Translation gain		-		51		51
Balances at December 31, 2020	$	(7,567)	$	245	$	(7,322)